3 Stocks to Buy in February

February is the shortest period of the year, truthful investors don't person arsenic overmuch clip to bargain large stocks arsenic they bash successful different months. And determination are plentifulness of beardown contenders to consider. Here are 3 stocks I deliberation should beryllium adjacent the apical of the database to bargain this month.

Amazon (NASDAQ: AMZN) has lagged good down the S&P 500 (SNPINDEX: ^GSPC) implicit the past 12 months. However, stock prices thin to travel net maturation sooner oregon later. Amazon's bottommost enactment is increasing robustly, driven successful portion by the company's initiatives to amended efficiency. I afloat expect this inclination volition proceed erstwhile Amazon reports its 2025 fourth-quarter results aboriginal this week.

Where to put $1,000 close now? Our expert squad conscionable revealed what they judge are the 10 champion stocks to bargain close now, erstwhile you articulation Stock Advisor. See the stocks »

I besides judge that agentic AI volition supply a beardown tailwind for Amazon Web Services (AWS) successful 2026. AWS gained momentum successful the 3rd quarter. As companies put much heavy successful deploying AI agents and statesman to spot returns connected those investments, Amazon's industry-leading unreality portion should payment tremendously.

Even with its banal soaring much than 50% implicit the past 12 months, I deliberation BeOne Medicines (NASDAQ: ONC) ranks among the astir underrated biotech stocks connected the market. BeOne's flagship product, Brukinsa, is present the golden modular for treating respective types of humor cancer. Sales for the blockbuster cause should proceed to emergence successful some the U.S. and Europe.

BeOne precocious received Chinese regulatory support for sonrotoclax for the attraction of relapsed/refractory (R/R) mantle compartment lymphoma (MCL) and R/R chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). It awaits U.S. support for the drug. The institution could besides soon record for accelerated support of BGB-16673 for the attraction of R/R CLL, pending affirmative results from a Phase 2 objective study.

Enterprise Products Partners (NYSE: EPD) looks similar an charismatic banal for income investors to scoop up successful February. This constricted concern (LP) offers a juicy guardant organisation output of 6.6%. Even better, Enterprise Products Partners has accrued its organisation for an awesome 27 consecutive years.

I deliberation there's 1 cardinal origin that could marque Enterprise Products Partners a bigger victor successful 2026 than it was past year. The roar successful the operation of caller information centers hosting artificial quality (AI) applications should construe to accrued request for the LP's earthy state pipelines. Enterprise believes that AI volition beryllium 1 of the 2 astir important drivers of maturation successful earthy state request implicit the adjacent 5 years.